Two-pore domain potassium channels: new sites of local anesthetic action and toxicity.
about
Two-pore domain potassium channels enable action potential generation in the absence of voltage-gated potassium channelsThe acid-sensitive, anesthetic-activated potassium leak channel, KCNK3, is regulated by 14-3-3β-dependent, protein kinase C (PKC)-mediated endocytic trafficking.TASK Channel Deletion Reduces Sensitivity to Local Anesthetic-induced Seizures.Expression of two-pore domain potassium channels in nonhuman primate sperm.Interaction of local anesthetics with the K (+) channel pore domain: KcsA as a model for drug-dependent tetramer stabilityThe corpus callosum modulates spindle-burst activity within homotopic regions of somatosensory cortex in newborn ratsShaker-related potassium channels in the central medial nucleus of the thalamus are important molecular targets for arousal suppression by volatile general anestheticsRegional expression of the anesthetic-activated potassium channel TRESK in the rat nervous system.Patents related to therapeutic activation of K(ATP) and K(2P) potassium channels for neuroprotection: ischemic/hypoxic/anoxic injury and general anesthetics.[EXPRESS] Role of dorsal root ganglion K2p1.1 in peripheral nerve injury-induced neuropathic pain.TREK-1 K(+) channels in the cardiovascular system: their significance and potential as a therapeutic target.Voltage-dependent blockade by bupivacaine of cardiac sodium channels expressed in Xenopus oocytes.Pharmacology of a slowly inactivating outward current in hippocampal CA3 pyramidal neurons.The effects of tracheal tube cuffs filled with air, saline or alkalinised lidocaine on haemodynamic changes and laryngotracheal morbidity in children: a randomised, controlled trial.Effectiveness of retigabine against levobupivacaine-induced central nervous system toxicity: a prospective, randomized animal study.The inhibitory effects of bupivacaine, levobupivacaine, and ropivacaine on K2P (two-pore domain potassium) channel TREK-1.Two-pore domain K⁺ channels regulate membrane potential of isolated human articular chondrocytes.Mechanism of Anesthetic Toxicity: Metabolism, Reactive Oxygen Species, Oxidative Stress, and Electron TransferThe Resting Potential and K Currents in Primary Human Articular Chondrocytes
P2860
Q26822748-83D07C4F-25FD-4DE7-BEC1-DCE8E5444D01Q28272135-C44172C1-5C93-42B1-B24F-EAAEB2D907B9Q30424160-49EDED92-4EF4-44CD-A41E-40BC8D0CD61BQ35752044-3F592884-7EFB-471A-90FD-08598A876D84Q37009060-2BE41ACE-815F-443A-8D39-E8E86D83E55AQ37160154-93B691D0-AB54-49FD-9ADE-FC92876BE69AQ37220104-76B84F99-AE91-49A6-A703-D7BCE91CA73BQ37423299-9CC418AE-C7D8-4D9F-97C1-9D908CABA21FQ37481320-277486CB-4EFC-47B3-823C-3EEE3AFA3DCEQ37722937-AE2916C7-32AE-4088-B7D6-93DE72752223Q37800140-283ABAFB-CC33-49F1-AA5D-614FADDA2584Q41458203-0250855E-D4B7-4FAA-A6A4-04D316D7E388Q46489707-7E3FB705-6C04-429F-B974-2109B16D2D19Q47352294-E5DEC847-C563-412E-9F23-10ED029753A1Q47660960-48CA0F01-1134-48B4-8946-A9FE6557118AQ47996266-C850C5F4-5FD4-4131-B2D9-00176BB8783BQ48231639-DFB8125B-172F-4E25-B0CE-5DDA86F96561Q58689352-BD5C4E1A-71EE-4CA1-A61D-E51B83F7A0E1Q58764678-68F88691-FCF0-4A2C-B7B8-0419145AB9D1
P2860
Two-pore domain potassium channels: new sites of local anesthetic action and toxicity.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Two-pore domain potassium channels: new sites of local anesthetic action and toxicity.
@ast
Two-pore domain potassium channels: new sites of local anesthetic action and toxicity.
@en
type
label
Two-pore domain potassium channels: new sites of local anesthetic action and toxicity.
@ast
Two-pore domain potassium channels: new sites of local anesthetic action and toxicity.
@en
prefLabel
Two-pore domain potassium channels: new sites of local anesthetic action and toxicity.
@ast
Two-pore domain potassium channels: new sites of local anesthetic action and toxicity.
@en
P1476
Two-pore domain potassium channels: new sites of local anesthetic action and toxicity.
@en
P2093
C Spencer Yost
Christoph H Kindler
P304
P356
10.1016/J.RAPM.2004.12.001
P577
2005-05-01T00:00:00Z